
Sign up to save your podcasts
Or


Longevity medicine is full of exciting ideas: rapamycin, peptides, supplements, and emerging therapies. But before worrying about any of them, have you actually assessed the diseases most likely to kill or disable you?
In this episode, Jon Brudvig, PhD and Dr. Grant Fraser walk through Dr. Fraser's approach to longevity-focused primary care: identifying disease early, measuring risk more directly, and addressing the fundamentals before moving on to more speculative interventions.
From cardiovascular imaging and metabolic health to cancer screening, bone density, frailty, infections, hearing loss, and cognitive decline, this conversation lays out a practical framework for understanding where you stand today—and what may be worth doing about it.
In this episode:
• Why “normal” labs and conventional risk scores don’t necessarily mean you’re disease-free
• Why Dr. Fraser puts cardiovascular and metabolic health at the top of the longevity hierarchy
• The role of coronary CT angiography, brain and vascular MRI, and other advanced imaging
• ApoB, lipoprotein(a), insulin sensitivity, blood pressure, omega-3 index, hsCRP, and other biomarkers
• Whole-body MRI for cancer screening—and the real tradeoff between early detection and false positives
• Why Grant uses low-dose lung CT even in some nonsmokers
• DEXA scans for bone density, visceral fat, body composition, and sarcopenia
• How infections and vaccination become increasingly important with age
• Hearing loss, dental health, vascular disease, and other overlooked contributors to cognitive decline
• Why diet, exercise, sleep, stress, and conventional prevention should come before the “clever” longevity interventions
Follow the hosts:
Jon Brudvig, PhD — Translation on Substack
https://jonbrudvig.substack.com
Grant Fraser, MD — Longevity & Precision Primary Care
https://www.grantfrasermd.com
In this episode, Jon Brudvig and Dr. Grant Fraser sit down with Dr. Natalia Mitin, co-founder and CEO of Sapere Bio, to explore one of longevity medicine’s biggest blind spots: how do we measure immune function and immune aging in an individual—and use that information to make better decisions?
From immune resilience, T-cell exhaustion, and cellular senescence to thymic regeneration, fisetin, rapamycin, GLP-1 drugs, exercise, and gut health, this conversation examines what it will take to move beyond population averages and toward truly personalized longevity medicine.
In this episodeNatalia Mitin, PhD, is the co-founder and CEO of Sapere Bio. Her work focuses on cellular senescence, immune aging, and biomarkers designed to evaluate immune resilience and monitor how it changes over time.
Are the biggest longevity gains hiding in plain sight?
In this episode, Jon Brudvig and Dr. Grant Fraser sit down with Dr. Gary Fraser, a pioneering epidemiologist behind the Adventist Health Studies, to explore what decades of human data reveal about diet, lifestyle, disease risk, and lifespan. From plant-based diets and nuts to exercise, body weight, dairy, fish, and processed foods, this conversation cuts through the noise to ask a simple question: what actually seems to help people live longer, healthier lives?
From the publisher's feed
Are you fully healthy, or are your cells in the Grey Zone between health and disease? GZL explores the latest longevity science to uncover what we can do now to detect risk earlier, restore…
Hosted by pharma scientist Jon Brudvig, PhD, and longevity physician Grant Fraser, MD, the show features conversations with scientists, physicians, biotech founders, and leaders in prevention and aging biology. GZL examines the interventions, biomarkers, drugs, lifestyle strategies, and emerging ideas that help us extend healthspan and change how we think about healthy aging.